IMS 2022 Annual Meeting

International Menopause Society
Congress on Menopause 2022

This program was supported by Bayer Inc.

doctor-patient

conference highlights

AUDIO & VIDEO CAPSULES

Moderated by Dr. Wendy Wolfman

This conference is available through our podcast

Abstract Summaries

Dr. Michelle Jacobson

MHT and breast cancer risk: progesterone versus synthetic progestins & Optimizing Hormone Therapy Through Choice Of Progestogen/Progesterone
IMS 2022
IMS 2022
Dr. Michelle Jacobson
Loading
/
[rating_form id="" custom_id="" score="false" total="false" stats="false" before_content="Rate this summary:"]

Watch video capsule

Abstract Summaries

Dr. Claudio Soares

Perimenopause As A Window Of Vulnerability For Depression: What Have We Learned So Far? + The Science Of Brain Fog At Menopause

IMS 2022
IMS 2022
Dr. Claudio Soares
Loading
/
[rating_form id="" custom_id="" score="false" total="false" stats="false" before_content="Rate this summary:"]

Watch video capsule

Abstract Summaries

Dr. Nese Yuksel

Menopause And Musculoskeletal Health

IMS 2022
IMS 2022
Dr. Nese Yuksel
Loading
/
[rating_form id="" custom_id="" score="false" total="false" stats="false" before_content="Rate this summary:"]

Watch video capsule

Abstract Summaries

Dr. Céline Bouchard

Sleep In The Menopausal Transition

IMS 2022
IMS 2022
Dr. Céline Bouchard
Loading
/
[rating_form id="" custom_id="" score="false" total="false" stats="false" before_content="Rate this summary:"]

Watch video capsule

Abstract Summaries

Dr. Jeanne Bouteaud

Menopausal Hormone Therapy After Cancers

IMS 2022
IMS 2022
Dr. Jeanne Bouteaud
Loading
/
[rating_form id="" custom_id="" score="false" total="false" stats="false" before_content="Rate this summary:"]

Watch video capsule

This program was supported by Bayer Inc. Statements of fact and opinions expressed are those of the speakers and do not necessarily reflect the opinions or position of Bayer Inc.

The contents of this site may contain information regarding indications and/or instructions which differ from the approved use of products available in Canada. For complete information, please refer to the respective product monographs available through the manufacturer’s website. The safety and efficacy of some of the products described herein are still under investigation and have not received market authorization from Health Canada.

This website is intended for Canadian healthcare professionals.

MA-M_ELINZA-CA-0011-1, MA-M_ELINZA-CA-0009-1, MA-M_ELINZA-CA-0010-1,
MA-M_ELINZA-CA-0013-1, MA-M_ELINZA-CA-0012-1